Article
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
9 Mar 2020
Abstract excerpt
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, and implementation of risk-adapted therapy has been instrumental in the dramatic improvements in clinical outcomes. A key to risk-adapted therapies includes the identification of genomic features of individual tumors, including chromosome number (for hyper- and hypodiploidy) and gene fusions, notably ETV6-RUNX1, TCF3-PBX1, and BCR-ABL1 in...
Topics
Join the communities discussing this publication.